Department of Hepatobiliary Surgery II,
General Surgery Center,
Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering,
Guangzhou Clinical Research and Transformation Center for Artificial Liver,
Institute of Regenerative Medicine,
Zhujiang Hospital,
Second Department of Hepatobiliary Surgery,
Second Department of Hepatobiliary Surgery, Zhujiang Hospital,
Department of Hepatobiliary Surgery II, General Surgery Center, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital
Lei Cai has not added Biography.
If you are Lei Cai and would like to personalize this page please email our Author Liaison for assistance.
Establishment of a Novel Simplified Surgical Model of Acute Liver Failure in the Cynomolgus Monkey.
BioMed research international , 2016 | Pubmed ID: 28097130
Artificial liver support in pigs with acetaminophen-induced acute liver failure.
World journal of gastroenterology May, 2017 | Pubmed ID: 28566885
Elimination of Contamination from Infected Human Hepatocyte C3A Cells by Intraperitoneal Injection in BALB/c Mice.
Frontiers in cellular and infection microbiology , 2017 | Pubmed ID: 29075618
Novel D-galactosamine-induced cynomolgus monkey model of acute liver failure.
World journal of gastroenterology Nov, 2017 | Pubmed ID: 29204057
Artificial Liver and Renal Support System for Cynomolgus Monkeys with Surgery-Induced Acute Renal Failure: A Preclinical Study.
BioMed research international , 2018 | Pubmed ID: 29992160
Establishment of gene-edited pigs expressing human blood-coagulation factor VII and albumin for bioartificial liver use.
Journal of gastroenterology and hepatology Oct, 2019 | Pubmed ID: 30884543
The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
Molecular oncology 05, 2019 | Pubmed ID: 30943320
Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1.
Journal of experimental & clinical cancer research : CR 11, 2019 | Pubmed ID: 31752959
Met allele Is Associated With Lower Cognitive Function in Poststroke Rehabilitation.
Neurorehabilitation and neural repair 03, 2020 | Pubmed ID: 32009534
Correction to: Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1.
Journal of experimental & clinical cancer research : CR 07, 2020 | Pubmed ID: 32635929
TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients.
Aging 11, 2020 | Pubmed ID: 33177245
Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma.
Frontiers in oncology , 2020 | Pubmed ID: 33224869
Correction to: Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1.
Journal of experimental & clinical cancer research : CR Jul, 2021 | Pubmed ID: 34271955
Co-amplification of genes in chromosome 8q24: a robust prognostic marker in hepatocellular carcinoma.
Journal of gastrointestinal oncology Jun, 2021 | Pubmed ID: 34295559
Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs.
Theranostics , 2021 | Pubmed ID: 34335954
Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model.
International journal of biological sciences , 2021 | Pubmed ID: 34512165
ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma.
Neoplasia (New York, N.Y.) 12, 2021 | Pubmed ID: 34768109
Case Report: One-Year Delay in the Effect of Conversion Surgery Therapy for Advanced Hepatocellular Carcinoma After Systemic Therapy.
Frontiers in molecular biosciences , 2021 | Pubmed ID: 35187075
In vitro safety and efficacy evaluation of a novel hybrid bioartificial liver system with simulated liver failure serum.
The International journal of artificial organs May, 2022 | Pubmed ID: 35416082
Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy.
Frontiers in immunology , 2022 | Pubmed ID: 36119069
Erratum: Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model: Erratum.
International journal of biological sciences , 2022 | Pubmed ID: 36439871
Establishment of acute liver failure model in Tibetan miniature pig and verified by dual plasma molecular adsorption system.
The International journal of artificial organs Mar, 2023 | Pubmed ID: 36600401
Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection.
Frontiers in oncology , 2023 | Pubmed ID: 36959801
Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B/RAS/MAPK axis in hepatocellular carcinoma.
Cellular oncology (Dordrecht) Oct, 2023 | Pubmed ID: 37099250
Magnetic Resonance Deep Learning Radiomic Model Based on Distinct Metastatic Vascular Patterns for Evaluating Recurrence-Free Survival in Hepatocellular Carcinoma.
Journal of magnetic resonance imaging : JMRI Oct, 2023 | Pubmed ID: 37888871